CG ONCOLOGY INC (CGON) Earnings History & Surprises
NASDAQ:CGON • US1569441009
61.88 USD
+1.51 (+2.5%)
At close: Mar 6, 2026
61.3 USD
-0.58 (-0.94%)
After Hours: 3/6/2026, 8:06:37 PM
Past quarterly earnings results for CG ONCOLOGY INC (CGON), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 27, 2026
PeriodQ4 / 2025
EPS Estimate-$0.63
Revenue Estimate484.5K
Last Reported
Release DateNov 14, 2025
PeriodQ3 / 2025
EPS Reported-$0.57
EPS Surprise 0.21%
Revenue Surprise 2,401.28%
Beat Rate
19%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.57 | -0.57 | 0.21% | -90.00% | 1.666M | 66.606K | 2,401.28% | 3,774.42% |
| Q2 2025 | -0.54 | -0.47 | -15.32% | -92.86% | 126.103K | -100.00% | -100.00% | |
| Q1 2025 | -0.45 | -0.41 | -9.38% | -25.00% | 52K | 217.005K | -76.04% | -90.17% |
| Q4 2024 | -0.48 | -0.36 | -33.19% | 89.02% | 456K | 76.5K | 496.08% | 45,500.00% |
| Q3 2024 | -0.30 | -0.37 | 19.89% | - | 43K | 106.284K | -59.54% | -78.82% |
| Q2 2024 | -0.28 | -0.38 | 26.21% | - | 111K | 179.857K | -38.28% | - |
| Q1 2024 | -0.36 | -0.30 | -21.70% | - | 529K | - | - | |
| Q4 2023 | -4.37 | -0.69 | -534.71% | - | 1K | - | - | |
| Q3 2023 | - | - | 203K | - | 6.28% | |||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | - | - | 191K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-14.42%
Max EPS beat (4)
0.21%
Min EPS beat (4)
-33.19%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
680.33%
Max Revenue beat (4)
2,401.28%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, CGON has beaten EPS estimates in 1 out of 4 releases
CGON has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, CGON reported -14.4% below the EPS estimates on average.
In the last 4 quarters, CGON has beaten the revenue estimates by 680.3% on average.
CG ONCOLOGY INC / CGON Earnings FAQ
Can you provide the last earnings date for CG ONCOLOGY INC?
CG ONCOLOGY INC (CGON) last reported earnings on 11/14/2025.
Can you provide information on whether CG ONCOLOGY INC beat earnings estimates in the last quarter?
CG ONCOLOGY INC (CGON) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does CGON stock beat earnings estimates?
In the last 4 quarters, CG ONCOLOGY INC (CGON) has beaten EPS estimates in 1 out of 4 releases.